Key Points
Munchen [Germany], October 5 (ANI): Researchers at LMU have successfully tested a novel medication that can greatly prolong the lives of patients with breast cancer...
Brain metastases are frequently observed in patients with advanced HER2-positive breast cancer..
Patients who experience this have little likelihood of surviving the following few years while receiving current treatments like radiotherapy and surgery..
Modern medicine divides breast cancer into different types according to tumorbiological characteristics. 50% of patients with advanced breast cancer and the tissue marker HER2 will suffer from brain metastases, which it has not been possible to treat successfully with drugs before now, as the blood-brain barrier often prevents active substances from penetrating into the brain..
Over 500 patients with and without brain metastases, from 78 cancer centers in Western Europe, Japan, Australia, and the United States, took part in the trial..
